Your browser doesn't support javascript.
loading
In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review.
Aslan, Abdullah Tarik; Ezure, Yukiko; Horcajada, Juan Pablo; Harris, Patrick N A; Paterson, David L.
Affiliation
  • Aslan AT; Faculty of Medicine, UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia.
  • Ezure Y; Faculty of Medicine, UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia.
  • Horcajada JP; Faculty of Medicine, UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia.
  • Harris PNA; Infectious Diseases Department, Hospital del Mar, Institut Hospital Del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Paterson DL; CIBERINFEC, ISCIII - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
Front Med (Lausanne) ; 10: 1249030, 2023.
Article in En | MEDLINE | ID: mdl-37727767
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Systematic_reviews Language: En Journal: Front Med (Lausanne) Year: 2023 Document type: Article Affiliation country: Australia Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Systematic_reviews Language: En Journal: Front Med (Lausanne) Year: 2023 Document type: Article Affiliation country: Australia Country of publication: Switzerland